<DOC>
	<DOCNO>NCT02661516</DOCNO>
	<brief_summary>The purpose study estimate impact bleed event patient UK non-valvular atrial fibrillation ( NVAF ) treat vitamin K antagonist ( VKA ) .</brief_summary>
	<brief_title>Clinical Economic Burden Bleeding Events Patients UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<criteria>For CPRDHES cohort , patient include meet criterion : Have CPRD data link HES Have AF diagnosis ( base Read code CPRD ICD10 cod HES ) treat VKA study period ≥18 year old index date CPRD acceptability quality criterion present . For CPRD cohort , patient include meet follow criterion : Have Atrial Fibrillation ( AF ) diagnosis ( base Read code CPRD ) treat VKAs study period ≥18 year old index date CPRD acceptability quality criterion present . For two cohort interest , patient exclude meet follow criterion : Fewer 12 month computerise data available prior index date ( order provide minimum amount computerise history avoid issue associate updating record patient join practice ) . The date start computerize record latter patient 's date registration practice practice 's UptoStandard ( UTS ) date ( practice deem contribute data adequate quality ) The practice UTS , patient deem `` unacceptable '' accord CPRD 's quality criterion There evidence valvular disease , repair , replacement ( ie , 12 month prior index date ) study period There record Novel anticoagulant ( NOAC )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>